Tafinlar ^*

Tafinlar (dabrafenib) is a targeted cancer drug used to treat specific cancers with a BRAF V600 gene mutation. These include certain types of melanoma skin cancer, non-small cell lung cancer (NSCLC), and anaplastic thyroid cancer. It is almost always prescribed in combination with another medication called trametinib. This combination approach helps to slow or stop the growth and spread of cancer cells by targeting specific pathways that fuel their growth.

Tafinlar should be taken exactly as your doctor prescribes, typically twice daily. The capsules are meant to be taken on an empty stomach, which means at least one hour before eating or two hours after. You should swallow the capsules whole with a glass of water and not crush or break them. Consistency is key, so try to take your doses approximately 12 hours apart to maintain a steady level of the medication in your body.

Tafinlar has specific instructions for missed doses. If you miss a dose, you should take it as soon as you remember. However, if your next scheduled dose is less than six hours away, you should skip the missed dose entirely. Do not take two doses at the same time to make up for a missed one, as this can increase your risk of side effects. Simply resume your regular dosing schedule.

Tafinlar is a long-term treatment, and you should not stop taking it even if you start to feel better. Stopping the medication without your doctor's approval can allow the cancer cells to start growing again, potentially undoing the progress made. Always consult your healthcare provider before making any changes to your treatment plan. They will monitor your condition and advise you on the appropriate duration of your therapy based on your response.

Tafinlar often causes several common side effects, especially when taken with trametinib. These frequently include fever, chills, fatigue, rash, nausea, vomiting, diarrhea, headache, and joint pain. Many of these side effects are manageable and may lessen over time as your body adjusts to the medication. However, you should always report any persistent or bothersome side effects to your healthcare provider for proper management and advice.

Tafinlar can cause various skin problems, including an increased risk of developing new skin cancers like squamous cell carcinoma. Because of this risk, your doctor will monitor your skin closely before and during treatment. You should also check your own skin regularly for any new warts, sores, or changes in moles. Other common skin side effects include rash and dryness. Report any new or worsening skin changes to your doctor immediately.

Tafinlar, particularly when combined with trametinib, may cause heart problems, including a condition called cardiomyopathy which affects the heart muscle's ability to pump blood. Your doctor will check your heart function before you start treatment and monitor it regularly while you are on the medication. You should immediately report any symptoms like shortness of breath, a racing heartbeat, or swelling in your ankles and feet to your healthcare provider.

Tafinlar can cause harm to an unborn baby, so you should not become pregnant while taking it. Your doctor will likely require a negative pregnancy test before starting treatment. It is crucial to use effective non-hormonal birth control during your treatment and for a period after your last dose, as Tafinlar can make hormonal contraceptives less effective. Discuss effective contraception methods with your healthcare provider before starting this medication.

Tafinlar and trametinib work together by blocking two different proteins in the same cancer growth pathway. While Tafinlar blocks the mutated BRAF protein, cancer cells can sometimes find a way around this blockage by using another protein called MEK. Trametinib works by blocking that MEK protein. Using both drugs at the same time creates a more complete and effective blockade of the signaling pathway, making it harder for the cancer to grow.

The BRAF V600E mutation is a specific change in the BRAF gene, which provides instructions for making a protein involved in cell growth. This mutation causes the protein to become overactive, sending constant signals that tell cells to grow and divide uncontrollably. This can lead to the development of cancer. Tafinlar is a targeted therapy designed to work specifically on cancers that are driven by this type of BRAF mutation.

Tafinlar capsules should be stored in their original container at room temperature, away from moisture and heat. It is not recommended to store this medication in a bathroom, as the humidity can affect the capsules. Make sure to keep the bottle tightly closed when not in use. As with all prescription medications, it is very important to keep Tafinlar out of the reach of children and pets to prevent accidental ingestion.

Tafinlar commonly causes fever, and while it is often mild, it can sometimes be a sign of a serious complication. A fever may be accompanied by chills, low blood pressure, or dizziness. Your healthcare provider may advise you to temporarily stop taking Tafinlar if you develop a fever. It is important to contact your doctor right away if you get a fever during your treatment so they can determine the cause and best course of action.

Tafinlar can sometimes lead to serious eye problems, including inflammation or retinal detachment. If you experience any vision changes, you should contact your doctor immediately. Symptoms to watch for include blurred vision, seeing colored dots, halos around lights, or any eye pain, swelling, or redness. Do not ignore these symptoms, as prompt medical attention is necessary to diagnose the issue and prevent any potential long-term damage to your vision.

Tafinlar may cause high blood sugar levels (hyperglycemia), or worsen existing diabetes, in some patients. Your doctor may monitor your blood sugar levels regularly while you are taking this medication, especially if you have a history of diabetes. Be sure to report symptoms of high blood sugar, such as increased thirst, frequent urination, or unusual fatigue, to your healthcare team so they can manage it appropriately.

Tafinlar is processed by the liver, and drinking alcohol can also put stress on your liver. While moderate alcohol consumption may be acceptable for some, it is best to discuss it with your doctor first. They can provide personalized advice based on your overall health, liver function, and any other medications you are taking. It is generally wise to limit alcohol intake to minimize any potential risk of liver-related side effects from your treatment.